Old Web
English
Sign In
Acemap
>
authorDetail
>
James P. Capo
James P. Capo
Solifenacin
Overactive bladder
Medicine
Urology
Tolerability
5
Papers
76
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and Tolerability of Solifenacin in Patients Aged ⩾ 65 Years with Overactive Bladder: Post-Hoc Analysis of 2 Open-Label Studies
2011
Postgraduate Medicine
James P. Capo
Vincent Lucente
Sergio Forero-Schwanhaeuser
Weizhong He
Show All
Source
Cite
Save
Citations (11)
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose study
2008
Clinical Therapeutics
Michael B. Chancellor
Norman R. Zinner
Kristene Whitmore
Kathleen C. Kobashi
Jeffrey A. Snyder
Paul Siami
Mickey M. Karram
Christine Laramée
James P. Capo
Raafat Seifeldin
Sergio Forero-Schwanhaeuser
Indrani Nandy
Show All
Source
Cite
Save
Citations (50)
Patients reporting severe overactive bladder symptoms: Effects of solifenacin treatment on objective measures and patient-reported outcomes
2008
James P. Capo
Marc R. Toglia
Sergio Forero-Schwanhaeuser
Weizhong He
Show All
Source
Cite
Save
Citations (0)
Solifenacin at 3 Years: A Review of Efficacy and Safety
2008
Postgraduate Medicine
Richard S Pelman
James P. Capo
Sergio Forero-Schwanhaeuser
Show All
Source
Cite
Save
Citations (14)
Solifenacin use in elderly patients with overactive bladder: VOLT and VERSUS data
2008
James P. Capo
Victor Lucente
Sergio Forero-Schwanhaeuser
Weizhong He
Show All
Source
Cite
Save
Citations (1)
1